1. Home
  2. GKOS vs MAT Comparison

GKOS vs MAT Comparison

Compare GKOS & MAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$121.28

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Logo Mattel Inc.

MAT

Mattel Inc.

HOLD

Current Price

$20.57

Market Cap

6.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
MAT
Founded
1998
1945
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Recreational Games/Products/Toys
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
6.5B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
GKOS
MAT
Price
$121.28
$20.57
Analyst Decision
Strong Buy
Buy
Analyst Count
14
9
Target Price
$130.93
$24.75
AVG Volume (30 Days)
728.9K
2.7M
Earning Date
02-17-2026
02-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.32
Revenue
$469,820,000.00
$5,227,568,000.00
Revenue This Year
$31.33
$1.92
Revenue Next Year
$24.01
$3.47
P/E Ratio
N/A
$15.77
Revenue Growth
30.38
N/A
52 Week Low
$73.16
$13.95
52 Week High
$163.71
$22.26

Technical Indicators

Market Signals
Indicator
GKOS
MAT
Relative Strength Index (RSI) 60.14 47.43
Support Level $93.96 $20.41
Resistance Level $130.23 $21.35
Average True Range (ATR) 5.30 0.67
MACD 0.75 -0.10
Stochastic Oscillator 74.39 25.49

Price Performance

Historical Comparison
GKOS
MAT

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About MAT Mattel Inc.

Mattel manufactures and markets toy products that are sold to its wholesale and direct to retail customers. The company offers products for children and families, including toys for infants and preschoolers, girls and boys, youth electronics, hand-held and other games, puzzles, educational toys, media-driven products, and plush and fashion-related toys. Mattel's owned portfolio includes Barbie, Hot Wheels, Fisher-Price, Thomas & Friends, and American Girl. In addition, it currently manufactures toy products for its segments both internally and externally (through manufacturing partners). Nearly 60% of its net sales were generated from North America in 2024, with the remainder stemming from international markets.

Share on Social Networks: